ClinicalTrials.gg
CompletedNCT00789230HUMPUpdated Feb 26, 2018

Mesh Versus Suture Repair for Umbilical Hernias

An interventional study of primary suture closure and mesh enforced closure in Umbilical Hernia, sponsored by Ruth Kaufmann, MD. Completed at 12 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-02-26.

Sponsored by Ruth Kaufmann, MD · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the present study is to investigate whether or not the use of mesh is indicated in the repair of all size umbilical hernias as to reduce the rate of recurrence. This method is regularly used in umbilical hernia reconstruction although most surgeons repair small hernias using suture repair (fascia adaptation). Especially risk factors for hernia recurrence such as hernia size and BMI > 30 kg/m2 need to be evaluated and correlated to the method of hernia repair.

Read the detailed description

Purpose The purpose of the present study is to investigate whether or not the use of mesh is indicated in the repair of all size umbilical hernias as to reduce the rate of recurrence. This method is regularly used in umbilical hernia reconstruction although most surgeons repair small hernias using suture repair (fascia adaptation). Especially risk factors for hernia recurrence such as hernia size and BMI > 30 kg/m2 need to be evaluated and correlated to the method of hernia repair.

Study design Randomised controlled, double blinded, multi-centre trial. 300 consecutive patients with an umbilical hernia will be included in the study. Patients will be randomised in one of two groups of 150 patients each. Group 1 will include patients that will undergo primary (suture) repair; group 2 umbilical hernias will be repaired using a pre-peritoneal, flat polypropylene mesh in a tension free fashion.

Stratification will be utilized for the size of the hernia (1-2 cm or ≥2-4 cm) and the participating centre. Patients will visit the outpatient clinic after 2-3 weeks and after 3, 12 and 24 months.

The cumulative hernia recurrence rate during the 2-years follow-up period will be the primary outcome of the study. Complications, pain and QOL are secondary endpoints.

Statistical analysis All analyses will be performed according to the intention to treat principle and as specified in the protocol.

Financial support None.

02

Conditions studied

  • Umbilical Hernia

Keywords

  • umbilical
  • hernia
  • mesh
03

In context

Hernia, Umbilical

67 studies on the registry are indexed under Hernia, Umbilical; 13 are open to participants now.

This study's enrollment of 300 is above the median of 66 across 40 interventional studies indexed under Hernia, Umbilical.

Browse Hernia, Umbilical studies →

Lead sponsor

This is the only study on the registry with Ruth Kaufmann, MD as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primary umbilical hernia
  • Signed

Exclusion criteria

Exclusion Criteria:

  • Umbilical hernia ≥ 4 cm diameter
  • Recurrence
  • Midline laparotomy
  • Ascites/Cirrhosis
  • IV or above
  • Incarcerated hernia/emergency procedures
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
300 participants (actual)

Study arms

  • Active comparator
    primary suture

    Procedure: primary suture closure

  • Active comparator
    mesh enforced closure

    Device: mesh enforced closure

Interventions

  • Procedureprimary suture closure

    primary suture closure of hernia

  • Devicemesh enforced closure

    mesh enforced closure of hernia

06

What researchers measure

Primary outcomes

  1. hernia recurrence rate

    Time frame: 24 months

Secondary outcomes

  1. Post-operative morbidity and complications

    Time frame: 3 months

07

Study locations

12 sites
  • Studienzentrum der Deutschen Gesellschaft für Chirurgie
    Heidelberg, Germany
  • University of Witten/Herdecke
    Witten, Germany
  • Multimedica
    Milano, Italy
  • Erasmus University Medical Center
    Rotterdam, Zuid Holland 3015CN, Netherlands
  • Onze Lieve Vrouwe Gasthuis
    Amsterdam, Netherlands
  • Wilhelmina Ziekenhuis
    Assen, Netherlands
  • Reinier de Graaf Gasthuis
    Delft, Netherlands
  • Havenziekenhuis
    Rotterdam, Netherlands
  • Ikazia
    Rotterdam, Netherlands
  • Maasstad Ziekenhuis
    Rotterdam, Netherlands
  • Máxima Medisch Centrum
    Veldhoven, Netherlands
  • Isala
    Zwolle, Netherlands
08

References and documents

Publications

  • Kaufmann R, Halm JA, Eker HH, Klitsie PJ, Nieuwenhuizen J, van Geldere D, Simons MP, van der Harst E, van 't Riet M, van der Holt B, Kleinrensink GJ, Jeekel J, Lange JF. Mesh versus suture repair of umbilical hernia in adults: a randomised, double-blind, controlled, multicentre trial. Lancet. 2018 Mar 3;391(10123):860-869. doi: 10.1016/S0140-6736(18)30298-8. Epub 2018 Feb 17. PubMed 29459021 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2006, a primary completion of Apr 2015 and a completion of Aug 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2008
First posted
Nov 11, 2008
Start
Jan 2006
Primary completionActual
Apr 2015
CompletionActual
Aug 2015
Last update
Feb 26, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00789230
Lead sponsor
Ruth Kaufmann, MD
Responsible party
Ruth Kaufmann, MD (R. Kaufmann, Erasmus Medical Center) — Sponsor-investigator
First posted
Nov 11, 2008
Start date
Jan 2006
Primary completion
Apr 2015
Completion
Aug 2015
Last update
Feb 26, 2018

Study contacts

J. Jeekel, MD, PhD
principal investigator · Erasmus Medical Center
J.F. Lange, MD, PhD
principal investigator · Erasmus Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion